The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
about
Exercise or exercise and diet for preventing type 2 diabetes mellitusStandards of medical care in diabetes--201210-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes StudyVascular repair strategies in type 2 diabetes: novel insightsTreatment of prediabetesTherapeutic Use of Metformin in Prediabetes and Diabetes PreventionThe reality of type 2 diabetes preventionIndependent and combined effect of diet and exercise in adults with prediabetesUsing the iPod Touch for Patient Health Behavior Assessment and Health Promotion in Primary CareHealthy Changes for living with diabetes: an evidence-based community diabetes self-management programTowards a comprehensive estimate of national spending on preventionHealthy hair starts with a healthy body: hair stylists as lay health advisors to prevent chronic kidney diseaseStandards of medical care in diabetes--2013Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.The prevention of type 2 diabetes.Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.Lifestyle change in Kerala, India: needs assessment and planning for a community-based diabetes prevention trial.Evaluation of lifestyle interventions to treat elevated cardiometabolic risk in primary care (E-LITE): a randomized controlled trial.Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention.The effect of ongoing feedback on physical activity levels following an exercise intervention in older adults: a randomised controlled trial protocol.Examining the economic costs related to lifestyle and pharmacological interventions in youth with Type 2 diabetes.Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.Many Americans have pre-diabetes and should be considered for metformin therapyCost-effectiveness analysis of voglibose for prevention of type 2 diabetes mellitus in Japanese patients with impaired glucose toleranceShort and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherenceThe Sydney Diabetes Prevention Program: a community-based translational study.Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapyDesign of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study.Costs and consequences associated with newer medications for glycemic control in type 2 diabetes.Retrospective study on the efficacy of a low-carbohydrate diet for impaired glucose tolerance.The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study.Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions.Individualized cost-effectiveness analysis.Rationale and design of the PREDICE project: cost-effectiveness of type 2 diabetes prevention among high-risk Spanish individuals following lifestyle intervention in real-life primary care settingCost-effectiveness of a mailed educational reminder to increase colorectal cancer screeningCost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review.Randomized trial of Tapas Acupressure Technique for weight loss maintenance: rationale and study design.Screening for prediabetes using machine learning models.Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.Cost-effectiveness of bariatric surgery for severely obese adults with diabetes.
P2860
Q24241914-AC2895E9-E4CC-49A1-BC35-641963E69D29Q24632533-769DCF83-9E78-41B0-883D-CE2392474771Q24633604-F0D1BD5E-7A53-4BA2-8FFB-25B3852D2CD2Q26778658-301731FA-2822-445E-A039-D80A498F9F97Q26783350-E5D42ABB-C709-43DB-97EC-1F7BF87E7874Q26822066-4DA65135-6B71-4A42-B0AF-DB69B2624E7EQ26825074-E5C4696C-2933-4226-ADFE-D675ADEA84C7Q26828591-7DB2F27B-1DDA-4994-82D6-FC174BD012A1Q28391246-16B87E18-957E-42C0-ABF4-C560FDFDCAE9Q28396979-669DED02-7F0D-452F-8798-BA5D117889D1Q28397070-34662107-C0B2-4CC6-9D7D-B2E24F5EA3EEQ28761777-C088948E-D57C-4BA7-83B7-D4FEF12C778AQ29620309-0A723E1F-3E7F-4092-BAFA-D1BDACB52501Q30392979-B78921DA-E885-4A86-93D6-8F575F51AD92Q30484253-E01DF630-F8CE-438E-8267-76D6CBB07C63Q30533186-27E84222-1592-4033-BE58-AFFB7C646CC6Q30536305-7049F8D7-6E01-426C-BE0A-60AD15FD636FQ30883786-484CBCC4-E5C7-4450-98A9-E20C68CA1AD9Q33411079-AB24E802-E4BF-4D7A-81A3-07DFB1BC71B8Q33452238-E9AF2A54-7F31-465A-BC5D-43E20D700803Q33506099-A23C6F4F-B328-4AD1-AFEE-0430327FAE68Q33534641-B918D321-7B9D-4E71-9D91-F0CECAEF2110Q33556877-1BBA43E4-8765-4B1A-B047-121406FCF456Q33585487-EA983827-AEDE-4E48-AACD-FEAAF30EDBFCQ33589814-3AA6B0CA-5AA0-4738-B56F-37C8B2374DE5Q33599450-67551156-3A4B-4093-BA04-63AAD7341031Q33610749-DA31BDCC-84A2-4E79-A8E2-4E25EF894EF4Q33653784-B7E42AC1-D3CC-49FD-AFFD-7EDF33C1BC26Q33751401-CB8C68A4-B266-4AB0-B874-7BA8CA38305BQ33779287-DAF21D3D-5FCA-43BC-BFB6-0E970E0B4499Q33801995-C800B091-2E3C-48E3-B29C-66E5F669B462Q33824231-995CF16C-9B70-4AC5-BE16-A1D97BBCEBF8Q33963712-30AFE8BA-A277-4FD0-A6E2-48950BA791BFQ33989592-CB3E1149-6D78-4909-B04F-88C130AC9B1EQ34002817-3295B2E5-7632-4DFB-8736-9773D3CE3A23Q34016162-C621C7D1-7B72-4365-8096-486604A30C99Q34071042-22DADA49-54A3-4FEB-A2CC-2B44300DE31CQ34073331-094CFC73-A4F4-4074-9069-EEB2A3C2C75EQ34073450-A41E58D1-7C0E-4DEB-B5A1-D9D5CFB1B0E1Q34084468-7BA31DD0-23B8-41CD-A869-6898C75E6B56
P2860
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The cost-effectiveness of life ...... th impaired glucose tolerance.
@en
The cost-effectiveness of life ...... th impaired glucose tolerance.
@nl
type
label
The cost-effectiveness of life ...... th impaired glucose tolerance.
@en
The cost-effectiveness of life ...... th impaired glucose tolerance.
@nl
prefLabel
The cost-effectiveness of life ...... th impaired glucose tolerance.
@en
The cost-effectiveness of life ...... th impaired glucose tolerance.
@nl
P2093
P2860
P921
P1476
The cost-effectiveness of life ...... th impaired glucose tolerance.
@en
P2093
Katherine Hicks
Michael Brandle
Michael M Engelgau
Ping Zhang
Richard F Hamman
Robert E Ratner
Ronald T Ackermann
Stephen Sorensen
Thomas J Hoerger
William H Herman
P2860
P304
P356
10.7326/0003-4819-142-5-200503010-00007
P407
P577
2005-03-01T00:00:00Z